Rarer safety concerns that need consideration in older adults are hypoglycaemia, dehydration, acute kidney injury, gallstones, and acute pancreatitis
Draw exceeds syringe capacity
Understand the conversion ratios between semaglutide and tirzepatide in case you need to switch medications
Dosing typically begins at a lower dose, suggested initiation of 4 units (0.04 mL) weekly for the first 4 weeks, then escalates according to a titration schedule: Weeks 1-4: Inject 4 units (0.04 mL) one time per week Weeks 5-8: Inject 8 units (0.08 mL) one time per week Weeks 9-12: Inject 18 units (0.18 mL) one time per week Weeks 13-16: Inject 30 units (0.3 mL) one time per week Week 16+: Inject 44 units (0.44 mL) one time per week Dosing may deviate from this pattern to accommodate patient-specific needs
Furthermore, our findings suggest that therapeutic modalities preserving kidney function could markedly benefit and reduce cardiovascular risk in individuals with high circulating TMAO in the presence of risk factors (T2D, hypertension, or metabolic syndrome)
All chemicals used were in analytical grade and were obtained from Sigma-Aldrich
